SHALBY145.25

Shalby Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersGKSLGPTHEALTHINDRAMEDCOARTEMISMEDLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹1,562 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations933.71,087.01,141.41,176.2
Other Income19.427.626.827.2
Total Income953.21,114.61,168.21,203.4
Expenses
+ Cost of Materials Consumed32.092.764.857.6
+ Purchases of Stock-in-Trade76.2103.9133.9146.6
+ Changes in Inventories-44.6-82.0-47.4-27.4
+ Employee Benefit Expense155.4184.6188.3189.6
+ Finance Costs16.038.739.040.2
+ Depreciation & Amortisation52.265.870.072.2
+ Other Expenses537.7655.2659.1667.0
Total Expenses825.01,058.81,107.71,145.8
EBITDA177.0132.6142.8142.8
EBIT124.866.872.870.6
Profit
PBT before Exceptional Items128.255.760.657.6
Pretax Income128.255.760.657.6
+ Current Tax59.656.544.037.6
+ Deferred Tax-14.9-2.7-18.1-17.5
Tax Expense44.753.825.920.1
Net Income83.51.934.737.5
+ Net Income — Continuing Ops83.51.934.737.5
+ Other Comprehensive Income0.6-2.6-24.7-23.8
Total Comprehensive Income84.1-0.710.013.7
Net Income to Common6.237.439.3
Minority Interest-4.3-2.7-1.8
Per Share
Basic EPS7.780.183.233.50
Diluted EPS7.770.183.233.50
Other Comprehensive Income — detail
+ Other Comprehensive Income-2.6-24.7-23.8
+ Items NOT to be Reclassified to P&L0.6-0.10.2-6.9
+ Tax on Items NOT to be Reclassified-0.1-0.0-0.1
+ Items to be Reclassified to P&L-24.9
+ Tax on Items to be Reclassified2.60.0
Comprehensive Income — Owners of Parent84.13.612.613.7
Comprehensive Income — Non-controlling Interests-0.6-4.3-2.7-1.3
Per Share — as-filed variants
Basic EPS — Continuing Operations7.780.003.233.50
Diluted EPS — Continuing Operations7.770.003.233.50
Basic EPS — Discontinued Operations0.000.180.000.00
Diluted EPS — Discontinued Operations0.000.180.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit870.2972.3990.1999.4
Gross Margin %93.1989.4686.7484.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)128.255.760.657.6
Net Income Adj (tax-effected)83.51.934.737.5
EPS Adj7.780.183.233.50
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital107.4107.5107.5107.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.